Veratridine (B7219): Benchmarking Sodium Channel Dynamics Research

Executive Summary: Veratridine (CAS: 71-62-5) is a steroidal alkaloid neurotoxin extracted from Veratrum species, acting as a potent voltage-gated sodium channel opener and preventing channel inactivation [APExBIO]. It is widely used in neuroscience and oncology to study sodium channel dynamics, excitotoxicity, and mechanisms of seizure. Recent animal data show Veratridine induces UBXN2A protein expression, enhancing cancer cell death in mortalin-2-dependent pathways (Saito et al., 2025). Its solubility in DMSO (>33.69 mg/ml) and strict storage requirements (-20°C) ensure experimental consistency. APExBIO’s Veratridine (B7219) is intended for research use only and is not suitable for diagnostic or clinical therapeutic applications.

Biological Rationale

Voltage-gated sodium channels (Nav channels) are essential for action potential initiation and propagation in excitable membranes, including neurons, cardiomyocytes, and muscle cells. Modulating these channels enables researchers to dissect the physiological and pathological states of excitability, signaling, and cellular death. Veratridine, as a sodium channel opener, creates a persistent depolarizing state by preventing channel inactivation. This unique effect is exploited in studies of excitotoxicity, seizure mechanisms, and screening of sodium channel blockers [PamidronateDisodium.com]. It also enables the study of cancer chemosensitivity, particularly via enhancement of the UBXN2A protein and induction of apoptosis in specific cancer models (Saito et al., 2025).

Mechanism of Action of Veratridine

Veratridine binds to site 2 of voltage-gated sodium channels (Nav1.x) on excitable cells. This binding prevents inactivation of the channel after activation, resulting in prolonged sodium influx and sustained depolarization [B-Pompilidotoxin.com]. The resultant persistent depolarization can trigger action potentials independent of physiological stimuli, facilitating the study of sodium channel function, excitotoxicity, and pharmacological screening of channel blockers. Excessive sodium influx, if not countered, leads to calcium overload and cell death, which is relevant in models of neurodegeneration, seizure, and cancer cell viability [MG-132.com]. The molecular formula is C36H51NO11, and the compound has a molecular weight of 673.79 g/mol. Veratridine is soluble in DMSO at concentrations exceeding 33.69 mg/ml (greater than 10 mM).

Evidence & Benchmarks

• Veratridine binds to site 2 of voltage-gated sodium channels, preventing inactivation and resulting in prolonged sodium influx (Saito et al. 2025, https://doi.org/10.1186/s13287-025-04656-0).
• Veratridine induces dose-dependent upregulation of UBXN2A protein in cancer cell lines, increasing apoptosis via mortalin-2-dependent pathways (Saito et al. 2025, https://doi.org/10.1186/s13287-025-04656-0).
• Intraperitoneal injection of Veratridine at 0.125 mg/kg for 28 days increases UBXN2A expression and reduces colon cancer cell viability in vivo (Saito et al. 2025, https://doi.org/10.1186/s13287-025-04656-0).
• Veratridine is routinely used in screening assays for sodium channel blockers, due to its robust and reproducible induction of sodium influx (APExBIO, https://www.apexbt.com/veratridine.html).
• High-purity Veratridine (SKU B7219, APExBIO) is stable at -20°C and is recommended for immediate use after solution preparation to avoid degradation (APExBIO, https://www.apexbt.com/veratridine.html).

Applications, Limits & Misconceptions

Veratridine is a cornerstone tool in:

• Sodium channel dynamics research: Dissecting channel gating and pharmacology in neurons and cardiomyocytes.
• Excitotoxicity studies: Modeling neurodegeneration and seizure-like states via persistent depolarization.
• Screening assays: Identifying candidate sodium channel blockers for therapeutic development.
• Cancer chemosensitivity modulation: Enhancing UBXN2A expression and promoting cell death in specific cancer models.
• Cardiomyocyte functional analysis: Used in chamber-specific differentiation protocols and disease modeling (see how this article extends recent translational guidance).

Common Pitfalls or Misconceptions

• Not for diagnostic or therapeutic use: Veratridine is strictly for research; clinical application is unsafe and unapproved.
• Degradation risk at room temperature: Solutions degrade rapidly at ambient conditions; always store at -20°C and use promptly.
• Cell- and context-specific effects: Efficacy and cytotoxicity vary by cell type and experimental conditions; always validate parameters.
• Misuse in viability assays: Overexposure or excessive concentrations can lead to non-specific cell death, confounding results.
• Not a universal sodium channel opener: Some Nav subtypes and non-mammalian channels may show limited sensitivity to Veratridine.

For expanded protocols, troubleshooting, and detailed use-cases in sodium channel research, see "Veratridine: Transforming Sodium Channel Dynamics Research". This article updates prior reports by integrating recent in vivo cancer and cardiomyocyte findings, taking a broader translational perspective.

Workflow Integration & Parameters

Veratridine (SKU B7219, APExBIO) is supplied as a white solid, with recommended dissolution in DMSO (>33.69 mg/ml, >10 mM). Solutions should be freshly prepared and used immediately to avoid degradation. Store dry powder at -20°C. In cell-based assays, effective concentrations range from 1 to 100 μM depending on cell type and objective. For in vivo mouse models, dosing at 0.125 mg/kg IP for 28 days has been validated for cancer studies (Saito et al., 2025). For sodium channel screening assays, titration from sub-micromolar to low micromolar is suggested, with parallel viability controls.

Refer to APExBIO’s product page for complete handling guidance and certificate of analysis: Veratridine B7219.

For scenario-driven bench protocols and troubleshooting, see "Veratridine (SKU B7219): Data-Driven Solutions for Sodium Channel Research". This article clarifies parameter optimization and stability considerations beyond the present mechanistic focus.

Conclusion & Outlook

Veratridine remains a gold-standard tool for dissecting voltage-gated sodium channel function, modeling excitotoxicity, and screening channel modulators. Its role in modulating UBXN2A and mortalin-2-dependent cancer cell death is expanding its utility into oncology research. APExBIO’s high-purity Veratridine (B7219) supports reproducible, high-resolution studies with defined storage and usage protocols. As advances in chamber-specific cardiomyocyte modeling and cancer chemosensitivity emerge, Veratridine’s precise mechanism and validated benchmarks will underpin the next wave of translational discovery (see how this article synthesizes cross-disciplinary insights).